Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

“Good Directors” Recruiting, Training & Placement (The Directors Letter)

Related Content

Medtech M&A and Venture Investments Show Renewed Strength

CFPB Report Identifies Areas for Improvement in State Data Privacy Laws

Life Sciences M&A Trends for 2023 and 2024 (Through End of Q3) in Greater China

Acting Comptroller Discusses Frameworks to Identify Systemic Risk

CFPB Finalizes Personal Financial Data Rights Rule

UK Employment: A Sea Change Ahead

California Expands Scope of Rosenthal Act to Cover Commercial Financial Transactions

OCC Issues Bulletin on Refinance Risk in Commercial Lending

BlueHalo To Be Acquired By AeroVironment In $4.1 Billion All-Stock Transaction

Goodwin Advises Biotheus in Agreement to be Acquired by BioNTech for $800 Million Upfront and $150 Million in Milestones

Clearwater Analytics Enters into Agreement to Terminate Tax Receivable Agreement for $72.5 Million

AlloVir and Kalaris Therapeutics to Merge

Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas

Retina Consultants of America To Be Acquired By Cencora For Up To $5.1 Billion

Aerovate Therapeutics to Combine with Jade Biosciences in All-Stock Transaction

Goodwin Advises HLTH in its Acquisition by Hyve

Mergers & Acquisitions